×
Sign up to our newsletter Click Here
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK
Ebola Virus Antigens
The Ebola virus (EBOV), a highly pathogenic, enveloped, non-segmented, negative-sense RNA virus, belongs to the genus Ebolavirus within the Filoviridae family. EBOV is the causative agent of Ebola Virus Disease (EVD), a severe hemorrhagic fever. Detection and analysis of its structural components, known as Ebola Virus Antigens, are critical for diagnostic assay development, medical research, and vaccine development.
Key structural proteins serve as the primary antigens used in immunoassays and research:
- Glycoprotein (GP): The Ebola Virus Glycoprotein (GP1,2) is the sole surface protein embedded in the viral envelope, forming a trimeric spike. Its functional importance lies in mediating host cell attachment and subsequent membrane fusion, which is essential for viral entry into target cells. The GP is the major protective antigen and therefore the primary target for neutralizing antibodies. The GP gene also produces soluble forms (sGP) via transcriptional RNA editing. Antigens based on specific strains, such as Zaire Ebolavirus (ZEBOV), are commonly used for research and detection purposes.
- Nucleoprotein (NP): The Ebola Virus Nucleoprotein (NP) is a core structural protein that tightly encapsulates the viral single-stranded RNA (ssRNA) genome, forming the nucleocapsid complex. NP is crucial for RNA encapsidation and plays a central role in the regulation of viral transcription and replication within the host cell. Recombinant NP from species like the Sudan Ebolavirus (SUDV) is often utilized in the development of ELISA and rapid test immunoassays to detect antibodies generated during infection.
- Viral Protein 40 (VP40): As the major matrix protein, Ebola Virus VP40 is situated beneath the viral envelope. It is fundamental to the virus’s life cycle, playing a key role in maintaining virion structural integrity, facilitating particle morphogenesis, and driving virion budding (egress) from the host cell membrane. VP40 is frequently co-expressed with GP to generate virus-like particles (VLPs) for research and vaccine platforms.
The availability of highly pure, recombinant forms of these antigens (GP, NP, VP40) is essential for developing reliable and specific antibody-based therapeutics and sensitive molecular detection methods.
